1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
106. C KNOOP, J ISMAILI, F BULTE, D <strong>ABRAMOWICZ</strong>, M GOLDMAN, M ESTENNE<br />
In vitro antigen presenting cell function is deficient in stable lung transplant recipients<br />
American Society of Transplantation Eighteenth annual meeting, Chicago, may 1999<br />
107. K.M. WISSING, D. <strong>ABRAMOWICZ</strong>, P. VEREERSTRAETEN<br />
Hypercholesterolemia is a risk factor for kidney graft loss from chronic rejection<br />
American Society of Transplantation Eighteenth annual meeting, Chicago, may 1999<br />
108. D <strong>ABRAMOWICZ</strong>, D MANAS, M LAO, Y VANRENTERGHEM, D DEL CASTILLO,<br />
D BARKER.<br />
Preliminary results of a randomized, controlled study investigating the withdrawal of<br />
Neoral in stable renal tranplant recipients receiving mycophenolate mofetil in addition to<br />
Neoral and steroids.<br />
American Society of Transplantation Eighteenth annual meeting, Chicago, may 1999<br />
109. M. WISSING, N. BROEDERS, A. SCHOUTENS, B. STALLENBERG, B. BORRE,<br />
D. <strong>ABRAMOWICZ</strong><br />
Effect of calcium and cholecalciferol treatment on bone mineral density in renal transplant<br />
recipients.<br />
Meeting of the American Society of Transplantation, Chicago, May 2001<br />
110. M.SURQUIN, A LE MOINE, V. FLAMAND, M. GOLDMAN, D. <strong>ABRAMOWICZ</strong><br />
CD4 Fas-FasL cytotoxicity represents one of the effector pathways responsible for the<br />
acute rejection of minor transplantation antigens,<br />
Meeting of the American Society of Transplantation, Chicago, May 2001<br />
111. J-C STOLEAR, F COLLART, M JADOUL, D <strong>ABRAMOWICZ</strong>, R CUVELIER,<br />
F JANSSEN, J-M KRZESINSKI, M DRATWA<br />
Transplant Activity in Middle-Aged ESRD Patients: A Cohort Study in Belgium<br />
World Congress of Nephrology, San Francisco, October 2001.<br />
112. D <strong>ABRAMOWICZ</strong>, Y VANRENTERGHEM, J-P SQUIFFLET, M MEURISSE,<br />
D KUYPERS, M MOURAD, J DAEMS<br />
Daclizumab and Mycophenolate Mofetil Allow for the Use of Low Doses of Tacrolimus<br />
and Steroids in Renal Transplantation: A Multi-Center, Pilot Study in De Novo Renal<br />
Transplantation.<br />
World Congress of Nephrology, San Francisco, October 2001.<br />
113. D <strong>ABRAMOWICZ</strong>, J-M MORALES, J-M CISTERNE, P ALTIERI, T MATHEW and<br />
the US, Global and tri-continental Study Groups<br />
Sirolimus-Based Immunosuppression Is Not Nephrotoxic in Renal Allograft Recipients<br />
54
Change language